Liver Perfusion Imaging in Patients with Primary and Metastatic Liver Malignancy

Prospective Comparison between 99mTc-MAA SPECT and Dynamic CT Perfusion
Published:January 30, 2012DOI:

      Rationale and Objectives

      To prospectively analyze the correlation between parameters of liver perfusion from technetium99m-macroaggregates of albumin (99mTc-MAA) single photon emission computed tomography (SPECT) with those obtained from dynamic CT perfusion in patients with primary or metastatic liver malignancy.

      Materials and Methods

      Twenty-five consecutive patients (11 women, 14 men; mean age 60.9 ± 10.8; range: 32–78 years) with primary (n = 5) or metastatic (n = 20) liver malignancy planned to undergo selective internal radiotherapy underwent dynamic contrast-enhanced CT liver perfusion imaging (four-dimensional spiral mode, scan range 14.8 cm, 15 scans, cycle time 3 seconds) and 99mTc-MAA SPECT after intraarterial injection of 180 MBq 99mTc–MAA on the same day. Data were evaluated by two blinded and independent readers for the parameters arterial liver perfusion (ALP), portal venous perfusion (PVP), and total liver perfusion (TLP) from CT, and the 99mTc-MAA uptake-ratio of tumors in relation to normal liver parenchyma from SPECT.


      Interreader agreements for quantitative perfusion parameters were high for dynamic CT (r = 0.90–0.98, each P < .01) and 99mTc -MAA SPECT (r = 0.91, P < .01). Significant correlation was found between 99mTc-MAA uptake ratio and ALP (r = 0.7, P < .01) in liver tumors. No significant correlation was found between 99mTc-MAA uptake ratio, PVP (r = −0.381, P = .081), and TLP (r = 0.039, P = .862).


      This study indicates that in patients with primary and metastatic liver malignancy, ALP obtained by dynamic CT liver perfusion significantly correlates with the 99mTc-MAA uptake ratio obtained by SPECT.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jakobs T.F.
        • Hoffmann R.T.
        • Poepperl G.
        • et al.
        Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres.
        Eur Radiol. 2007; 17: 1320-1330
        • Dancey J.E.
        • Shepherd F.A.
        • Paul K.
        • et al.
        Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
        J Nucl Med. 2000; 41: 1673-1681
        • Dudeck O.
        • Zeile M.
        • Wybranski C.
        • et al.
        Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy.
        Eur Radiol. 2010; 20: 2699-2706
        • Campbell A.M.
        • Bailey I.H.
        • Burton M.A.
        Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy.
        Phys Med Biol. 2000; 45: 1023-1033
        • Leen E.
        • Goldberg J.A.
        • Anderson J.R.
        • et al.
        Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis.
        Gut. 1993; 34: 554-557
        • Bledin A.G.
        • Kim E.E.
        • Chuang V.P.
        • et al.
        Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intra-arterially injected technetium 99m macroaggregated albumin.
        Br J Radiol. 1984; 57: 197-203
        • Bilbao J.I.
        • de Martino A.
        • de Luis E.
        • et al.
        Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings.
        Cardiovasc Intervent Radiol. 2009; 32: 727-736
        • Flamen P.
        • Vanderlinden B.
        • Delatte P.
        • et al.
        Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
        Phys Med Biol. 2008; 53: 6591-6603
        • Ho S.
        • Lau W.Y.
        • Leung T.W.
        • et al.
        Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.
        Br J Radiol. 1997; 70: 823-828
        • Knesaurek K.
        • Machac J.
        • Muzinic M.
        • et al.
        Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.
        Technol Cancer Res Treat. 2010; 9: 253-262
        • Miles K.A.
        • Hayball M.P.
        • Dixon A.K.
        Functional images of hepatic perfusion obtained with dynamic CT.
        Radiology. 1993; 188: 405-411
        • Haberland U.
        • Klotz E.
        • Abolmaali N.
        Performance assessment of dynamic spiral scan modes with variable pitch for quantitative perfusion computed tomography.
        Invest Radiol. 2010; 45: 378-386
        • Goetti R.
        • Leschka S.
        • Desbiolles L.
        • et al.
        Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases.
        Invest Radiol. 2010; 45: 419-426
        • Meijerink M.R.
        • van Waesberghe J.H.
        • van der Weide L.
        • et al.
        Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience.
        Acad Radiol. 2009; 16: 1215-1222
        • Ippolito D.
        • Sironi S.
        • Pozzi M.
        • et al.
        Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
        Acad Radiol. 2008; 15: 919-927
        • Fournier L.S.
        • Oudard S.
        • Thiam R.
        • et al.
        Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
        Radiology. 2010; 256: 511-518
        • Chen Y.
        • Zhang J.
        • Dai J.
        • et al.
        Angiogenesis of renal cell carcinoma: perfusion CT findings.
        Abdom Imaging. 2010; 35: 622-628
        • Goh V.
        • Halligan S.
        • Wellsted D.M.
        • et al.
        Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.
        Eur Radiol. 2009; 19: 79-89
        • Chen G.
        • Ma D.Q.
        • He W.
        • et al.
        Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
        World J Gastroenterol. 2008; 14: 5738-5743
      1. Saddi KA, Chefd'hotel C, Cheriet F. Large deformation registration of contrast-enhanced images with volume-preserving constraint. In: Pluim JPW, Reinhard JM, eds. Medical Imaging 2007: Image Processing. Bellingham, WA: Proceedings of The International Society for Optical Engineering (SPIE), 2007.

        • Blomley M.J.
        • Coulden R.
        • Dawson P.
        • et al.
        Liver perfusion studied with ultrafast CT.
        J Comput Assist Tomogr. 1995; 19: 424-433
        • Tsushima Y.
        • Funabasama S.
        • Aoki J.
        • et al.
        Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data.
        Acad Radiol. 2004; 11: 215-223
        • Hamami M.E.
        • Poeppel T.D.
        • Muller S.
        • et al.
        SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
        J Nucl Med. 2009; 50: 688-692
        • Ahmadzadehfar H.
        • Sabet A.
        • Biermann K.
        • et al.
        The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.
        J Nucl Med. 2010; 51: 1206-1212
        • Gyves J.W.
        • Ziessman H.A.
        • Ensminger W.D.
        • et al.
        Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT).
        J Nucl Med. 1984; 25: 972-977
        • Goldberg J.A.
        • Bradnam M.S.
        • Kerr D.J.
        • et al.
        Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II.
        Nucl Med Commun. 1987; 8: 1025-1032
        • Ho S.
        • Lau W.Y.
        • Leung T.W.
        • et al.
        Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
        Eur J Nucl Med. 1996; 23: 947-952
        • Bilbao J.I.
        • Garrastachu P.
        • Herraiz M.J.
        • et al.
        Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.
        Cardiovasc Intervent Radiol. 2010; 33: 523-531
        • Veit-Haibach P.
        • Treyer V.
        • Strobel K.
        • et al.
        Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
        Abdom Imaging. 2010; 35: 528-536
        • Cuenod C.
        • Leconte I.
        • Siauve N.
        • et al.
        Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT.
        Radiology. 2001; 218: 556-561
        • Breedis C.
        • Young G.
        The blood supply of neoplasms in the liver.
        Am J Pathol. 1954; 30: 969-977
        • Kandel S.
        • Kloeters C.
        • Meyer H.
        • et al.
        Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results.
        Eur Radiol. 2009; 19: 2641-2646
        • Youn S.W.
        • Kim J.H.
        • Weon Y.C.
        • et al.
        Perfusion CT of the brain using 40-mm-wide detector and toggling table technique for initial imaging of acute stroke.
        AJR Am J Roentgenol. 2008; 191: W120-W126
        • Helck A.
        • Sommer W.H.
        • Klotz E.
        • et al.
        Determination of glomerular filtration rate using dynamic CT-angiography: simultaneous acquisition of morphological and functional information.
        Invest Radiol. 2010; 45: 387-392
        • Goh V.
        • Liaw J.
        • Bartram C.I.
        • et al.
        Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques.
        AJR Am J Roentgenol. 2008; 191: W288-W292
        • Goh V.
        • Dattani M.
        • Farwell J.
        • et al.
        Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis.
        Eur Radiol. 2011; 21: 974-981
        • Kierkels R.G.
        • Backes W.H.
        • Janssen M.H.
        • et al.
        Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
        Int J Radiat Oncol Biol Phys. 2010; 77: 400-408
        • Goetti R.
        • Reiner C.S.
        • Knuth A.
        • et al.
        Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
        Invest Radiol. 2012; 47: 18-24
        • Kapanen M.
        • Halavaara J.
        • Hakkinen A.M.
        Comparison of liver perfusion parameters studied with conventional extravascular and experimental intravascular CT contrast agents.
        Acad Radiol. 2007; 14: 951-958
        • Leung W.T.
        • Lau W.Y.
        • Ho S.K.
        • et al.
        Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.
        J Nucl Med. 1994; 35: 70-73